Miso Clinic · Clinical column

Skin Boosters Compared at a Glance — Ingredients · What They Do · Reversibility · Level of Evidence

“What's the difference between Rejuran, Rituo and Gouri?” When I get this question in the clinic, I first draw a table on paper. They're grouped under the similar name ‘skin booster,’ but the material, what it does in the body, whether it can be reversed after injection, and the thickness of confirmed human data all differ. This article reproduces that table as it is. There's no ranking. Instead, I've written which cell to look at first for which concern.

Clinical column about 9 min October 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

The skin booster comparison table sets Rejuran (PN) · Rituo (hADM) · Gouri (liquid PCL) · Juvelook (PDLLA) · hyaluronic acid boosters · diluted Radiesse (CaHA) side by side in five columns: ingredients, what they do, reversibility, level of evidence, and concerns they suit. Of the six, only the hyaluronic acid line can be dissolved and reversed with an injection (hyaluronidase), and there's no agent that dissolves CaHA. The thickness of evidence differs too: the Rituo line has a 20-person split-face randomized trial (exploratory in scale), Byryzn a 20-person single arm, and published human data for liquid PCL is at case-report scale. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) has all six, and instead of ranking products we first work out whether what has decreased is texture, thickness or volume, then choose (clinical judgement).

What do the six look like in one table?

The table below is the body of this article. Read it left to right: what goes in → what it does in the body → whether it can be reversed → how much human data there is → which concern it's looked at first for.

Six skin boosters compared
Product (type)IngredientsWhat is doneReversible?Level of evidenceConcerns it suits
Rejuran (PN)Polynucleotide purified from salmon milt + hyaluronic acid + lidocaine (HB PLUS)Works on the dermis's recovery environment without creating volumeNo reversing injection, but a material that breaks down3D measurement study of 28 people without a control group; a review of randomized trials noted small samplesTexture · fine lines · sensitized skin, first booster
Rituo (hADM)Dermal matrix with the cells removed from donated human skinDirectly adds the dermal material that has decreasedNo reversing injection; a material that breaks downSplit-face double-blind randomized trial of 20 people · 20 weeks (hyaluronic acid control), exploratory in scaleSkin whose dermis has thinned and needs support
Gouri (liquid PCL)Liquid polycaprolactone without particlesSpreads as a sheet along the layer it's placed in, targeting texture · densityNo reversing injectionPublished human data for the liquid type is at the scale of 2 case reportsTexture and density across the whole face
Juvelook (PDLLA)PDLLA particles + non-cross-linked hyaluronic acidStays where placed and draws out a collagen responseNo reversing injection4 pilot studies (10–20 people); no published randomized controlled trial results confirmedTexture · fine lines in a defined area
Hyaluronic acid boosters (Byryzn, etc.)Cross-linked hyaluronic acid (Byryzn contains 0.3% lidocaine)Draws in water and physically supports the dermisYes — dissolves with hyaluronidaseByryzn 20-person single arm over 12 weeks; 11-person biopsy showing collagen increase after hyaluronic acid injectionDryness · tightness; when you want to start with room to reverse
Diluted Radiesse (CaHA)Calcium hydroxylapatite microspheres + gel, used dilutedCollagen response around the microspheres; diluted, it shifts toward texture rather than volumeNo — there's no agent that dissolves CaHAReview of 13 controlled CaHA studies · 1,171 people; one 20-person dilution study · no comparison between ratiosTexture · elasticity in places where volume mustn't be added, like the neck

The ‘level of evidence’ column shows the design and scale of published human data for that line, not the size of the effect. There's no large randomized trial yet pitting the lines against each other on the same outcome, so “which works best” can't be answered with data.

Which can be reversed after injection?

A major axis dividing the six is room to reverse. Cross-linked hyaluronic acid can be dissolved with an enzyme injection called hyaluronidase. The other five are materials that break down gradually in the body, so they don't stay permanently, but there's no means of reversing them right after injection.

  • Hyaluronic acid boosters — dissolve with hyaluronidase. Even if the Tyndall effect, a bluish show-through from shallow placement as around the eyes, occurs, it can be reversed.
  • Rejuran (PN) · Rituo (hADM) — materials that break down. They don't create much volume, so the starting burden is relatively low.
  • Gouri (PCL) · Juvelook (PDLLA) — no reversing injection. So we start on the low side and decide at 4 weeks whether to add (clinical judgement).
  • Radiesse (CaHA) — no dissolving agent. In a review analysing 5,081 treatments, nodules topped the list of common adverse events, and nodule management isn't dissolving but stepwise dispersing or removal.

So Miso Clinic doesn't give the explanation “if it doesn't work out, we can just dissolve it.” For first-timers we mention reversible lines or lines that break down first (clinical judgement). What can and can't be dissolved is set out separately in Hyaluronidase — what can be reversed.

How should the level of evidence be read?

Even with the same “there's research,” the weight differs if the design differs. Re-laying the six's human data by design gives this.

Confirmed human data by line, and its limits
CategoryConfirmed human dataLimitations
PN (Rejuran)3D measurement of eye-area wrinkles, 28 people · 18 weeks; wrinkles · texture · pores p<0.05 (Kim JH 2022)No control group. A review of 7 PN · PDRN randomized trials · 183 people also noted small samples
hADM (Rituo)Split-face double-blind randomized, 20 people · 20 weeks, hyaluronic acid on the other side (NCT07155278)Exploratory in scale. No published human trial of CellREDM itself confirmed
Liquid PCL (Gouri)2 case reports, 2 sessions 4 weeks apart · 12 weeksThe +26.7% dermal-thickness biopsy is data on microsphere-type (suspension) PCL
PDLLA (Juvelook)4 pilots, 10–20 peopleNo published randomized controlled trial results confirmed
Cross-linked HA (Byryzn)Single arm of 20 people; wrinkle scale 2.60 → 1.55 at 8 weeks, holding about a 33% reduction at 12 weeksNo control group; transient nodule in 1 person
Diluted CaHA (Radiesse)Review of 13 controlled CaHA studies · 1,171 people · dilution biopsy in 20 people on the neck · décolletageThe review noted risk of bias made pooled analysis difficult. No study comparing dilution ratios with each other

There are two tips for reading it. First, studies without a control group can show “it improved” but not whether it was “because of that treatment.” Second, “no adverse events were reported” and “there are no adverse events” are different. At a scale of 20–30 people, rare reactions may not be caught. How to read studies is also written in Retracted evidence and how to read it.

How do they split by what they do?

By what they do in the body, the six fall into three broad groups.

Three groups by what they do
TypeAppliesExplanation
Putting material in directlyRituo (hADM) · hyaluronic acid boostersAdds lost matrix or water-holding material right where it's needed
Changing the environmentRejuran (PN)Works on an environment where the dermis can recover well, without creating volume
Drawing out the body's responseGouri (PCL) · Juvelook (PDLLA) · Radiesse (CaHA)Stimulates the body to make collagen around the material

Even within the third group, spreading or staying divides them. Gouri has no particles, so it spreads as a sheet along the layer it's placed in, while Juvelook · Radiesse stay where placed. So to treat a wide surface evenly, the spreading type fits; to concentrate on a defined area, the staying type. There's also a biopsy showing type I · III procollagen increased as hyaluronic acid physically stretched the dermis (Wang 2007, 11 people), so the distinction “boosters make collagen, fillers only fill” isn't accurate. A detailed comparison is in Gouri and other collagen boosters.

What do you look at first by concern?

If you settle in one sentence what has decreased now rather than a product name, the cell to look at is nearly decided.

Concern → booster to look at first (clinical judgement)
Main concernWhat we look at firstReason
Rough texture and lots of fine linesRejuran · JuvelookSuited to dividing widely into a shallow layer
Skin has thinned and lacks firmnessRituo · CellREDM (hADM)Directly adds the dermal material that has decreased
The whole face is dull and density has droppedGouriA formulation that spreads as a sheet without particles
It's dry and tightHyaluronic acid boosterDraws in water, and can be reversed
Places where volume mustn't be added, like the neckDiluted RadiesseDiluted, it shifts toward texture rather than volume, but it can't be reversed
Having a booster for the first timeHyaluronic acid boosters · RejuranReversible or breaks down, so a low-burden start

Many people fall under two or more. In that case, rather than putting everything in, we do the one that bothers you first, check the condition after 4 weeks, then decide the next (clinical judgement). The first branch by concern is set out in the hub article Skin boosters in Daegu: where to start.

Are there differences even within the same cell?

Yes. A cell in the table is a line name, not a single product.

  • PCL — Gouri is a liquid type without particles, and there's also a suspension-type PCL with microspheres floating in gel. The ingredient is the same but how it spreads and the evidence differ (The difference between liquid and microsphere PCL).
  • CaHA — undiluted it leans toward volume; diluted, its character shifts toward texture. There's one 20-person dilution study and no study comparing ratios (What diluting CaHA means).
  • hADM — Rituo and CellREDM are in the same line but differ in formulation such as particle size. CellREDM has particles of about 75 μm (manufacturer's published figure). There's no data directly comparing the two products.
  • PN — Rejuran HB PLUS is a product combining PN with hyaluronic acid and lidocaine. The difference between PN and PDRN is written separately in The difference between PN and PDRN.

One more thing worth knowing. Korean approval wording generally describes these products as “temporary improvement of facial wrinkles.” Collagen production isn't within what the approval guarantees but an area research deals with, so Miso Clinic doesn't say things like “collagen increases by X%.” hADM products such as Rituo are also materials subject to human-tissue legislation.

In these cases we look at routes other than boosters

  • When hollow cheeks · temples are the main concern — boosters aren't volume-filling treatments. We look at fillers (The difference between filler and boosters).
  • A blurred jawline and descended cheeks — structural sagging, the domain of radiofrequency lifting devices (Booster or lifting?).
  • Shadow of an under-eye groove — we first consider placing hyaluronic acid filler deep (Choosing an eye-area skin booster).
  • Lines that deepen only when smiling — the domain of botulinum toxin.
  • When there's inflammation · infection at the treatment site or you're pregnant · breastfeeding — we postpone or discuss first.

If the injection site becomes increasingly painful after treatment, the skin turns white or purplish, or a hard lump grows, contact us right away.

Skin booster comparison: frequently asked questions

Which skin booster works best?

There's no data to rank them. There's no large randomized trial yet pitting the lines against each other on the same outcome, and each line targets something different. If you first decide whether what has decreased is texture, thickness or volume, the cell to look at is decided.

Which skin boosters can be dissolved and reversed?

Only the cross-linked hyaluronic acid line. It dissolves with hyaluronidase. Rejuran · Rituo are materials that break down, and Gouri · Juvelook · Radiesse have no reversing injection. There's no agent that dissolves CaHA either.

How do Rituo and Rejuran differ?

Rituo directly adds matrix derived from human dermis (hADM), while Rejuran works on the recovery environment with PN purified from salmon. The representative data are a 20-person split-face randomized trial for the Rituo line and a 28-person 3D measurement study without a control for PN.

Aren't Gouri and Juvelook both collagen boosters?

Both draw out the body's collagen response, but Gouri has no particles and spreads as a sheet while Juvelook's particles stay where placed. So we look at Gouri first for texture and density across the whole face, and Juvelook for texture in a defined area.

If I'm having a skin booster for the first time, what's a safe choice?

We mention reversible hyaluronic acid boosters or Rejuran, which breaks down, first. It's not too late to look at irreversible materials once the direction is clear.

Where can I get a skin booster comparison consultation in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Clinical columns to read next

Product reference

Related notes: Rejuran · Rituo · Gouri · Juvelook · Byryzn · Radiesse · booster comparison

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. Rejuran HB PLUS — made by Pharma Research, PN + hyaluronic acid + lidocaine, Korean medical device. The course of 3–4 sessions 3–4 weeks apart is Miso Clinic’s recommended design.
  2. 3D measurement study of PN around the eyes — Kim JH et al., Aesthetic Plastic Surgery 2022;46(4):1902. PN injected for eye-area wrinkles, 30 enrolled · 28 completed · 18 weeks, Antera 3D measurement. Wrinkle grade p<0.001, wrinkles · texture · pores p<0.05, no change in melanin. A before-and-after design without a control group.
  3. PN · PDRN literature review — Cureus 2026. 7 randomized trials · 183 people. The authors wrote that samples were small and protocols varied, so randomized trials of sufficient scale are still needed.
  4. Level of PN evidence — Polynucleotides in Aesthetic Medicine: Current Practices and Perceived Effectiveness, Int J Mol Sci 2024 (evidence grade and limitations) · Expert Perspectives: Evidence-Based Applications of Polynucleotides, Clin Cosmet Investig Dermatol (that it is not a volumiser).
  5. Re2O split-face trial — Yonsei University Severance Hospital, split-face double-blind randomised trial (NCT07155278), International Journal of Molecular Sciences 2026. 20 people · 20 weeks · Re2O on one side, hyaluronic acid on the other. Exploratory in scale.
  6. CellREDM product information — made by Hans Biomed (Korean rights Hugel). hADM fine particles about 75 μm (manufacturer’s figure). We found no published human trial of CellREDM itself.
  7. Human tissue rules — Act on the Safety and Management of Human Tissue (tissue bank licence Art. 13 · import Art. 17). MFDS Notice No. 2026-340 of 16 July 2026 gave advance notice of an amendment to the enforcement rules; not promulgated as of September 2026.
  8. Human data on liquid PCL — 2 Australian case reports (women aged 28 · 32, 2 sessions 4 weeks apart, 12-week follow-up, mean patient rating 4.0 · practitioner rating 3.0). The dermal-thickness biopsy (Kim JS, Aesthetic Surgery Journal 2019;39(12):NP484, 13 people · mean age 38.7, opposite temple as control) was done with a suspension-type PCL containing microspheres, so it isn't carried straight over to the liquid type (Gouri).
  9. Dermal thickness and pores are different variables — in human biopsy of microsphere PCL, dermal thickness +26.7% ± 9.3% at 1 year (13 people, P < 0.001). This is dermal thickness data, not data measuring pores as the primary variable.
  10. Human data on PDLLA — 4 pilot studies: Seo 2024 (20 people, face) · Ma 2024 (10 people, back of hands, 3 sessions 3 months apart) · Lin 2022 (10 people, lower eyelid) · Seo 2024 (20 people, with CO₂ laser, stretch marks). Increased COL1A1 · COL3A1 expression in a mouse model. No published results of randomized controlled trials confirmed. The Korean product (Juvelook) contains non-cross-linked hyaluronic acid together with PDLLA.
  11. Byryzn human study — Lee JH et al., J Cosmet Dermatol 2024;23(2):409–416, DOI 10.1111/jocd.15944. Prospective · single-centre · single-arm pilot, 20 people (mean age 54.1), 3 intradermal injections 2 weeks apart, observed 12 weeks. Lemperle wrinkle scale 2.60 ± 0.60 → 1.55 ± 0.51 at 8 weeks (about 40% reduction), held at about 33% at 12 weeks. Transient subcutaneous nodule in 1 person. No control group.
  12. Byryzn product information — Hugel brand · made by ACROSS. Cross-linked hyaluronic acid + lidocaine 0.3%, two 1.1 mL syringes (box labelling). Medical device (biomaterial for tissue repair), intended use “temporary improvement of facial wrinkles in adults.” The approval number was not found in public sources; 62026-I10-23-2790 on promotional material is a medical advertising pre-review number.
  13. Hyaluronic acid and collagen — Wang F, Fisher GJ, Voorhees JJ et al., Archives of Dermatology 2007;143(2):155. Biopsies at 4 · 13 weeks after cross-linked hyaluronic acid injection into photoaged skin (11 people, mean age 74, saline control). Increased type I · III procollagen expression (P<.05).
  14. Korean approval of CaHA — Radiesse: MFDS approval 2010; intended use temporary improvement of facial wrinkles · temporary restoration of hand volume (2017); microspheres 25–45 μm · 30% of total weight (Merz). Dclassy: made by CGBio · supplied by DNC Aesthetics; tissue repair material; intended use temporary improvement of facial wrinkles; sizes 0.8 mL · 1.5 mL. I couldn't confirm any published clinical trial of Dclassy itself.
  15. Systematic review of CaHA — Journal of Clinical Medicine 2024. 13 controlled studies · 1,171 people; noted risk of bias in design and differences between studies made pooled analysis difficult.
  16. CaHA safety — Safety of Calcium Hydroxylapatite: A Review (2017), adverse-event analysis of 5,081 treatments — nodules were the most common. Management of Nodules Following CaHA Injection, Aesthetic Surgery Journal 2024 — stepwise management. There's no agent that dissolves CaHA.
  17. CaHA dilution — 2017 neck · décolletage study, 20 people, 1:2 · 1:4 · 1:6 assigned by skin thickness, type I collagen increased on biopsy at baseline · 4 · 7 months. Not a study comparing ratios with each other.
  18. Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
  19. Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語